A recent study reveals many websites selling compounded versions of weight-loss drugs do not inform users of risks, often ...
Websites selling compounded versions of popular weight-loss drugs from Novo Nordisk and Eli Lilly to U.S. consumers often do ...
Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...
Eli Lilly & Co. ( LLY) thinks its next experimental weight-loss pill could get approved as soon as early 2026.
In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
With rumours about celebrities using semaglutide drugs like Ozempic for quick weight loss the question remains Are these anti ...
This practice is not approved by the U.S. Food and Drug Administration (FDA). "Health care clinicians do not typically ...
Wegovy, the weight-loss brand of semaglutide, has a recommended maintenance dose of 2.4 mg. Novo ran the Phase III STEP UP ...
Global health highlights include a court pausing a generic version of a heart drug, Novo Nordisk's weight loss trial success, ...